Vitamin Stock Easy Pill to Swallow After Weed Deal

The shares just touched an 11-year high earlier this week

by Lillian Currens

Published on Jun 12, 2019 at 10:09 AM

The shares of Neptune Wellness Solutions Inc (NASDAQ:NEPT) are surging on the charts yet again, after the Canadian nutrition products specialist announced its partnership with Green Organic Dutchman. According to the deal, the latter company will supply cannabis and hemp biomass to NEPT, which will manufacture the finished products. The stock has jumped 4.1% to trade at $4.83 this morning, in response. 

NEPT stock has been popping on the charts, gapping higher on a Tilray (TLRY) deal last week. In fact, the equity just hit an 11-year high of $5.22 on Monday. While the stock has only enjoyed one close atop the $5 region during its recent surge, NEPT has managed to tack on over 90% this year. 

While analysts are relatively quiet on Neptune, the two that do follow the stock gave it a "buy" or better rating. Plus, the consensus 12-month target price of $6.02 sits in territory not charted since September 2007, and is a 25% premium to current levels. 

Options traders, on the other hand, have leaned in a bearish direction. While NEPT only sports a 10-day put/call volume ratio of 0.19 on the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX), the ratio sits higher than 88% of all other readings from the past year. This indicates put buying has been quicker-than-usual, relative to call buying, in recent weeks.

 


a schaeffer's exclusive

5 HOT STOCK PICKS

Heat up your summer trading with this FREE insider report!


 
 

Partnercenter


NEW! Explore Schaeffer’s Partners' deals and get connected to top online brokerages with deals tailored exclusively for our readers.  Get answers to your questions regarding transfer fees, commission rates, programs and available discounts related to online trading services.

MORE | MARKETstories


Become a Master of Moving Averages
How you can transform lagging indicators into leading indicators.
Impressive NASH Drug Data Sends Pharma Stock Up Again
BMO just downgraded DOW stock to "market perform"
Red-Hot Disney Stock Slapped With Rare Downgrade
The bear note comes amid valuation concerns
Become a Master of Moving Averages
How you can transform lagging indicators into leading indicators.